Ceramide Moisturisers — What They Do, What They Don't, and Why the System Matters More Than the Ingredient
If you are looking at ceramide moisturisers, you are asking a sensible question. Ceramides are a real barrier ingredient — one of the few in skincare where the mechanism is well-established and the evidence holds up. But the ceramide label has been applied to a very wide range of products, and most of them are doing something, not everything that the label implies.
This article explains what ceramides actually do in the skin barrier, what they cannot do on their own, and what to look for when evaluating a ceramide moisturiser — so the product you choose is doing the job you need it to do. For the full explanation of how barrier repair works and what it requires, see our guide to skin barrier repair.
What Ceramides Are
Ceramides are lipid molecules — not a single ingredient — that form the structural foundation of the skin barrier's intercellular matrix.
You have probably seen ceramide NP, ceramide AP, or ceramide EOS on an ingredient list and had no way to know whether the letters matter, whether more species is better, or whether a product with one ceramide is meaningfully different from one with three. These are the right questions to be asking — and this article answers them.
Ceramides are a class of sphingolipids — lipid molecules composed of a sphingoid base linked via an amide bond to a fatty acid chain. The human stratum corneum contains at least 12 distinct ceramide subclasses, classified by the nature of their sphingoid base (sphingosine, phytosphingosine, sphinganine, 6-hydroxysphingosine) and their fatty acid head group (non-hydroxy, alpha-hydroxy, omega-hydroxy). Together, ceramides account for approximately 50% of total stratum corneum lipid mass by weight — the dominant lipid class in the skin barrier (Elias, Journal of Investigative Dermatology, 1983).
The naming convention — ceramide NP, AP, EOS, NS — reflects these subclasses. Ceramide NP (non-hydroxy fatty acid / sphingosine base) is among the most abundant ceramide species in the stratum corneum and the most commonly used in cosmetic formulations. Ceramide AP (alpha-hydroxy fatty acid / phytosphingosine) is also present in normal skin and physiologically relevant. Ceramide EOS is an acylceramide — a longer-chain species covalently bonded to the outer surface of corneocytes, forming the template on which the lamellar lipid matrix assembles. Each species occupies a different structural role. A formulation with multiple ceramide species more closely approximates the skin's own ceramide diversity than a single-species product.
What makes ceramides structurally significant is not their presence alone but their organisation. In the stratum corneum's intercellular space — the matrix between corneocyte cells — ceramides are arranged into repeating lamellar sheets alongside cholesterol and free fatty acids. This lamellar architecture is the primary physical barrier the skin uses to regulate water loss. The ceramide molecule contributes to that structure. The organisation determines how well it functions.
What Ceramides Do in the Skin
Ceramides are a structural ingredient, not a hydrating one. Their contribution to skin comfort is indirect — and understanding that distinction changes what you should expect from a ceramide product.
The stratum corneum's intercellular lipid matrix creates a tortuous pathway for water vapour moving outward through the skin. Ceramides are critical structural contributors to this pathway. When ceramide content falls — through ageing, barrier disruption, or chronic environmental stress — lamellar organisation deteriorates and transepidermal water loss (TEWL) rises. Topical ceramide NP integrates into the SC lamellar matrix and has been shown to reduce TEWL within 24–72 hours of consistent application (Proksch et al., Journal of Dermatology, 2005; Bouwstra et al., Progress in Lipid Research, 2003).
Ceramides do not attract water. They are not humectants. Their contribution to skin comfort is indirect: by reducing TEWL, they allow the skin's own water-retention mechanisms — the natural moisturising factor (NMF) inside corneocytes — to function without constant depletion. A ceramide-containing product applied to dehydrated skin will not produce an immediate sensation of hydration. Over 24–72 hours of consistent use, as TEWL falls and intracorneocyte water content recovers, skin comfort improves. This is the correct clinical expectation. Most ceramide product marketing does not set it.
"Ceramides are not a hydrating ingredient. They are a structural ingredient. The distinction determines what you should expect from a ceramide moisturiser — and how long to give it."
Ceramide depletion is well-documented across several skin conditions. Ceramide content declines measurably with age — beginning in the third decade and accelerating through the fourth and fifth — with parallel increases in TEWL (Rogers et al., Archives of Dermatological Research, 1996). In atopic dermatitis, ceramide depletion is among the most robustly documented barrier phenotype features, with significant reductions in ceramide NP, NS, and total ceramide content relative to healthy controls (Ong et al., Journal of Allergy and Clinical Immunology, 2008). In xerosis, reduced ceramide content correlates with elevated TEWL and impaired barrier recovery. The case for ceramides in barrier support formulations is not marketing — it rests on consistent clinical evidence across multiple research contexts.
In Indian skin at Fitzpatrick phototypes IV–VI, there is additional relevance: this skin profile shows higher baseline TEWL than age-matched Caucasian populations despite comparable or higher stratum corneum hydration — a pattern consistent with lamellar lipid insufficiency rather than NMF deficit alone (Cosmed Media, ethnic TEWL comparative data). Chronic barrier stressors common in urban Indian environments progressively deplete SC ceramides, making lamellar lipid support a sustained requirement rather than a one-time correction.
The Ceramide Moisturiser Category
Not all ceramide moisturisers are architecturally equivalent. The ceramide species, concentration, complementary ingredients, and delivery vehicle all determine what the product can accomplish at the barrier level.
The ceramide moisturiser category spans a wide range — from rich barrier creams built around multiple ceramide species in lamellar emulsion bases, to lightweight serums containing a single ceramide species at trace concentration in an aqueous vehicle. Both will appear on ingredient lists as "ceramide NP." The label does not distinguish them.
Ceramide Species and Concentration
The 12 ceramide subclasses in the stratum corneum occupy different structural roles. Ceramide NP and ceramide NS are among the most abundant and most clinically validated for topical use. Ceramide AP and ceramide EOS contribute to specific aspects of lamellar organisation. A moisturiser listing ceramide NP only is providing one species into a multi-species system. A formulation with ceramide NP, ceramide AP, and ceramide EOS (or ceramide NS) is covering a broader range of the structural roles the lamellar matrix depends on.
Concentration matters in a practical sense, though cosmetic ingredient lists are not required to disclose percentage amounts. Ceramide NP is typically used at 0.1–1% in functional formulations. At trace concentrations (below 0.01%), the ingredient qualifies for label inclusion but the physiological contribution at the barrier level is limited. A useful proxy: where does ceramide appear on the ingredient list? Listed after fragrance or at the very end of a long INCI typically indicates a trace amount. Listed in the mid-section of a balanced formulation more likely indicates a functional concentration.
Cream vs. Serum Format
Format matters for ceramide delivery. A ceramide in a water-light serum with a fast-evaporating vehicle leaves the stratum corneum surface quickly, with minimal residual film. A ceramide in a structured emulsion — particularly a lamellar liquid-crystalline emulsion — is delivered in an architectural context that shares organisational properties with the SC's own lamellar matrix, supporting more organised lipid deposition. Two products with identical ceramide content but different vehicle architectures can produce meaningfully different TEWL outcomes. Fast absorption into skin is not evidence of superior ceramide delivery — it often indicates a thin residual film, which is the opposite of what barrier-compromised skin needs.
What Ceramides Cannot Do Alone
Ceramides address the lamellar lipid component of barrier dysfunction. Barrier-compromised skin has multiple simultaneous deficits. Ceramides alone do not resolve all of them.
This is where the ceramide narrative in skincare diverges from the science. Ceramides are genuinely important — but they are one component in a multi-component barrier system. The evidence is consistent on this point across multiple research groups.
The stratum corneum's intercellular lipid matrix is not a ceramide matrix. It is a three-component system: ceramides (~50% by mass), cholesterol (~25%), and free fatty acids (~15%), present at an approximate molar ratio of 1:1:1 in normal, non-aged skin (Elias, Journal of Investigative Dermatology). Research by Mao-Qiang and Elias demonstrated that all three components are necessary for organised lamellar recovery following barrier disruption, and that supplying ceramides without the complementary lipid classes can impair rather than accelerate organised lamellar deposition (Mao-Qiang et al., Archives of Dermatology, 1993). A ceramide moisturiser that contains ceramide NP without complementary lipid coverage is adding one component to a three-component problem.
Beyond lipid architecture, barrier-compromised skin has further deficits that ceramides do not address. Ceramides reduce water loss — they do not attract water. A ceramide barrier that reduces TEWL still requires adequate water content in the stratum corneum to confer comfort, which requires a humectant co-system. Without one, the ceramide slows water loss but the skin remains dehydrated. The humectant function is itself conditional on ambient humidity: in low-humidity environments — air-conditioned Indian interiors commonly run at 30–45% RH — a physically persistent surface film is needed to retain attracted water against evaporation. A ceramide moisturiser without film-forming architecture provides structural support and water attraction but no mechanism for keeping that water in place.
There is also the question of the skin's own ceramide production. The skin synthesises ceramides endogenously — and in chronically barrier-compromised skin, this synthesis pathway is often suppressed by the inflammatory environment. Niacinamide at 2–4% is the most evidence-supported complement to topical ceramide NP because it directly supports the skin's capacity to produce its own ceramides (Tanno et al., British Journal of Dermatology, 2000). A ceramide moisturiser with niacinamide addresses both the exogenous deficit and the endogenous suppression — without it, the product is managing the symptom but not the underlying dynamic.
The ceramide question I kept returning to during Terra's formulation was not whether to include ceramide NP — that answer was clear. It was what to build around it. A ceramide in a water-light serum vehicle does real work for perhaps the first thirty minutes after application. After that, without film-forming architecture and without adequate humectancy, the water that the ceramide barrier has reduced the loss rate of simply leaves through other routes. The formulation gap is not usually the ceramide. It is everything the ceramide needs in order to function across the day.
Why the System Matters More Than the Ingredient
The move from ingredient thinking to system thinking changes what you look for in a ceramide moisturiser — and why most ceramide products produce partial rather than sustained improvement.
The characteristic failure of ceramide-only products is not that they are physiologically irrelevant. They do real work. It is that they are physiologically incomplete. They address one deficit in a multi-deficit condition and leave the others unresolved. The result is partial improvement — a mild reduction in TEWL, a modest initial improvement in comfort — that does not sustain, because the adjacent deficits continue to drive the cycle of discomfort.
The pattern that most people with chronically barrier-compromised skin recognise is this: the product helps initially, comfort improves, and then over a period of days or weeks the skin returns to its baseline state of tightness or dehydration. This is not a product failure in the narrow sense — the ceramide did what ceramides do. It is an architectural failure. The formulation was not built to address all the points at which the barrier is failing simultaneously.
Barrier repair is documented in the physiological literature as a multi-mechanism process: lamellar lipid restoration, humectant replenishment, film-forming retention, suppression of the inflammatory environment that inhibits endogenous lipid synthesis, and delivery vehicle architecture that supports organised lipid deposition rather than just surface application. A ceramide moisturiser that addresses only the first of these five mechanisms is doing approximately one-fifth of what chronically compromised skin needs (as established across the Elias group's barrier repair research and subsequent clinical ceramide literature).
"A ceramide moisturiser is not evaluated by its ceramide content. It is evaluated by what the formulation does around the ceramide — and whether that architecture is complete."
The ingredient list of a ceramide moisturiser should be evaluated against all of these requirements — lipid support, humectancy, film-forming retention, endogenous synthesis support — not only against whether ceramide NP appears near the top of the INCI. That is the shift from ingredient thinking to formulation thinking, and it is the difference between a product that helps temporarily and one that holds. The concept that connects this to lasting skin comfort is hydration persistence — the distinction between skin that is temporarily hydrated and skin that stays that way.
How to Evaluate a Ceramide Moisturiser
Five questions that move evaluation beyond the ceramide label toward the formulation architecture that determines what the product can actually do.
1. Which ceramide species, and where on the list?
Ceramide NP and ceramide NS are the most clinically validated species for topical barrier support. Ceramide AP and ceramide EOS extend coverage across additional structural roles in the lamellar matrix. A product listing multiple ceramide species covers more of the matrix's ceramide diversity than a single-species product. Position on the INCI list gives a rough indication of concentration: ceramide appearing after fragrance or at the tail end of a long list is likely at a trace amount. Functional concentrations (typically 0.1–0.5% for ceramide NP in a serum; higher in denser creams) appear earlier in the list.
2. Is there complementary lipid support?
The SC lipid matrix is a three-component system — ceramides, cholesterol, and free fatty acids. A ceramide formulation without complementary lipid coverage is addressing one component of a three-component problem. Look for plant oils supplying linoleic and oleic acid (raspberry seed oil, rosehip oil, prickly pear seed oil), phospholipids such as hydrogenated lecithin, and emollients such as squalane. A ceramide moisturiser that lists ceramide NP and then little else in the lipid column is incomplete by design.
3. Is there a meaningful humectant system?
Ceramides reduce water loss — they do not attract water. A ceramide moisturiser without adequate humectancy provides structure without content. Glycerin is the most physiologically relevant humectant for barrier-compromised skin, with demonstrated reservoir function superior to surface-only humectants under low-humidity conditions (Fluhr et al., British Journal of Dermatology, 2008). Betaine, amino acids, and related compounds strengthen the humectant system. High-molecular-weight hyaluronic acid as the sole humectant is insufficient for chronically compromised skin in low-humidity indoor environments.
4. Is there film-forming architecture?
The vehicle determines whether attracted water is retained or evaporates. A ceramide moisturiser in a fast-evaporating vehicle leaves a thin residual film. At indoor humidity of 30–45%, that film is insufficient to hold water at the skin surface. Film-forming ingredients — hydrolysed proteins, polysaccharides such as pectin or carrageenan, or a lamellar emulsion base — extend how long attracted water stays put. A ceramide product that disappears immediately after application is telling you something about its residual architecture.
5. Is there endogenous synthesis support?
The skin produces its own ceramides — and in chronically barrier-compromised skin, that production is often diminished by the local inflammatory environment. Niacinamide at 2–4% is the most evidence-supported complement to topical ceramide NP, with documented upregulation of endogenous ceramide biosynthesis in keratinocytes (Tanno et al., British Journal of Dermatology, 2000). A ceramide moisturiser with functional-concentration niacinamide covers both the exogenous supply and the medium-term recovery of the skin's own synthesis capacity.
Terra is not a ceramide serum. It is a hydration persistence system for skin that is tired of being repeatedly rescued. Ceramide NP is one component within a six-system formulation architecture — present at functional concentration, but not the centre of the design.
- Barrier Lipid SupportCeramide NP alongside hydrogenated lecithin, squalane, kokum seed butter, raspberry seed oil, and prickly pear seed oil — complementary lipid coverage across the three-component matrix, not ceramide in isolation
- Multi-Pathway HumectancyGlycerin, betaine, sodium polyglutamate crosspolymer, and free amino acids — water attraction across distinct mechanisms, with reservoir function that holds under low-humidity conditions
- Film-Forming Persistence + Endogenous SupportHydrolysed wheat and soy proteins, pectin, Chondrus crispus extract, and niacinamide at functional concentration — a persistent surface film combined with support for the skin's own ceramide synthesis pathway
Frequently Asked Questions
Do ceramide moisturisers actually work for dry skin?
Ceramides have clinical evidence supporting their role in TEWL reduction and barrier recovery — ceramide NP integrates into the SC lamellar matrix and reduces water loss within 24–72 hours of consistent application (Proksch et al., Journal of Dermatology, 2005). For dry skin caused primarily by lamellar lipid insufficiency, a ceramide moisturiser with complementary lipid support and adequate humectancy addresses the root deficit. For skin that is repeatedly losing comfort despite using ceramide products, the issue is usually that the ceramide is present but the formulation architecture around it — humectancy, film-forming retention, anti-inflammatory support — is incomplete. The ceramide is doing its job. The system is not complete enough for it to sustain.
What is the difference between ceramide NP and other ceramide types?
Ceramide NP (non-hydroxy fatty acid / sphingosine base) is one of the most abundant ceramide species in the human SC and the most clinically validated for topical use. It integrates into the lamellar matrix and contributes to the short-periodicity lipid phase that governs barrier permeability. Ceramide AP (alpha-hydroxy fatty acid / phytosphingosine) occupies a different structural role within the same matrix and is also physiologically relevant. Ceramide EOS is an acylceramide — covalently anchored to the corneocyte surface, providing the template on which the lamellar matrix assembles. A formulation with multiple ceramide species covers a broader range of structural roles than ceramide NP alone. Neither is a substitute for the other, but ceramide NP is the evidence-supported baseline for barrier repair formulations.
Is a ceramide face cream better than a ceramide serum?
Format is less important than formulation architecture. A ceramide in a water-light serum vehicle that evaporates quickly provides surface ceramide delivery with a thin residual film — effective for barrier-intact skin that needs maintenance support, less effective for chronically compromised skin that needs sustained TEWL reduction. A ceramide in a lamellar emulsion — whether cream or serum format — is delivered in a vehicle that shares structural properties with the SC's own lipid matrix, supporting more organised ceramide deposition and leaving a functional residual film. For oily or combination skin types with barrier compromise (a very common phenotype in Indian skin), a moisturising serum that provides the structural benefits of a cream without the occlusive weight is often the more appropriate format.
Can I use a ceramide moisturiser with retinol or acids?
Yes — and for skin using retinoids or chemical exfoliants, a ceramide-containing moisturiser is particularly relevant. Both retinoids and high-concentration AHAs transiently elevate TEWL and thin the SC during their active phase. A ceramide moisturiser applied alongside or after these actives provides structural lipid support during the barrier perturbation window — the 24–72 hour period in which the skin's own lamellar body secretion is rebuilding the disrupted matrix. The ceramide does not cancel the active's mechanism; it supports the barrier while that mechanism operates. The key is to ensure the ceramide moisturiser also has anti-inflammatory support (niacinamide, allantoin) that reduces the cytokine response that retinoids and exfoliants can trigger at the barrier level.
Why does my skin still feel tight after using a ceramide moisturiser?
Tightness after a ceramide moisturiser points to one of three incomplete formulation situations: the product lacks adequate humectancy (ceramides reduce water loss but do not attract water, so the SC remains under-hydrated despite improved barrier function); the vehicle evaporates quickly, leaving insufficient residual film to retain moisture in low-humidity conditions; or the NMF pool within corneocytes has not been adequately supported — intracorneocyte water-binding capacity is a separate deficit from lamellar lipid status. Tightness is the skin's signal that the water content problem has not resolved, regardless of whether the TEWL rate has improved.
How long does it take for a ceramide moisturiser to work?
For TEWL reduction, ceramide NP begins integrating into the SC lamellar matrix within hours of application, with measurable TEWL reduction typically observable within 24–72 hours of consistent use (Proksch et al., 2005). Subjective skin comfort — the reduction of tightness, the stabilisation of dryness — follows as intracorneocyte hydration rebuilds in response to lower TEWL. For skin with chronic barrier compromise, where the inflammatory environment is suppressing endogenous ceramide synthesis, the benefit from a well-formulated ceramide moisturiser builds over two to four weeks of consistent daily use rather than being evident in the first application. Immediate sensation of hydration is not the right expectation for a ceramide product — sustained reduction of discomfort over hours and days is.
- Elias, P.M. "Epidermal lipids, barrier function, and desquamation." Journal of Investigative Dermatology, Vol. 80, Suppl. 1, 1983, pp. 44–49.
- Bouwstra, J.A., Honeywell-Nguyen, P.L., Gooris, G.S., Ponec, M. "Structure of the skin barrier and its modulation by vesicular formulations." Progress in Lipid Research, Vol. 42, No. 1, 2003, pp. 1–36.
- Proksch, E., Lachapelle, J.M. "The management of dry skin with topical emollients — recent perspectives." Journal of Dermatology, Vol. 32, No. 7, 2005, pp. 476–480.
- Rogers, J., Harding, C., Mayo, A., Banks, J., Rawlings, A. "Stratum corneum lipids: the effect of ageing and the seasons." Archives of Dermatological Research, Vol. 288, No. 12, 1996, pp. 765–770.
- Ong, P.Y., Leung, D.Y. "Bacterial and viral infections in atopic dermatitis: a comprehensive review." Journal of Allergy and Clinical Immunology, 2008. Referenced for ceramide depletion in atopic dermatitis phenotype.
- Mao-Qiang, M., Feingold, K.R., Elias, P.M. "Exogenous lipids influence permeability barrier recovery in acetone-treated murine skin." Archives of Dermatology, Vol. 129, No. 6, 1993, pp. 728–738. Referenced for three-component lipid system and lamellar recovery.
- Fluhr, J.W., Darlenski, R., Surber, C. "Glycerol and the skin: holistic approach to its origin and functions." British Journal of Dermatology, Vol. 159, No. 1, 2008, pp. 23–34. PMC 3396453. Referenced for AQP3-mediated glycerol humectancy.
- Brandt, E.B., Sivaprasad, U. "Th2 cytokines and atopic dermatitis." Journal of Clinical and Cellular Immunology, 2011. PMC 10451066. Referenced for inflammatory suppression of endogenous ceramide synthesis in barrier-compromised skin.
- Tanno, O., Ota, Y., Kitamura, N., Katsube, T., Inoue, S. "Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier." British Journal of Dermatology, Vol. 143, No. 3, 2000, pp. 524–531.
- Cosmed Media. "Who has the driest skin? Ethnic characteristics of facial skin hydration." Referenced for TEWL comparison across skin phototypes including Fitzpatrick IV–VI.